Precipio, Inc. (NASDAQ:PRPO – Get Free Report) passed above its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of $6.09 and traded as high as $7.00. Precipio shares last traded at $6.61, with a volume of 4,876 shares changing hands.
Precipio Stock Performance
The business has a 50 day moving average price of $5.99 and a two-hundred day moving average price of $6.09. The company has a market cap of $9.79 million, a P/E ratio of -3.61 and a beta of 1.42. The company has a debt-to-equity ratio of 0.02, a quick ratio of 0.60 and a current ratio of 0.73.
Precipio (NASDAQ:PRPO – Get Free Report) last released its quarterly earnings results on Wednesday, November 6th. The biotechnology company reported ($0.42) EPS for the quarter. The business had revenue of $5.21 million for the quarter. Precipio had a negative net margin of 17.23% and a negative return on equity of 34.01%.
About Precipio
Precipio, Inc, a healthcare solutions company, provides diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; and HemeScreen, a suite of robust genetic diagnostic panels.
See Also
- Five stocks we like better than Precipio
- How to Invest in Insurance Companies: A GuideĀ
- 3 Must-Have ETFs Set to Dominate This Quarter
- What is the Euro STOXX 50 Index?
- Seeking Stability? These 3 Stocks Offer Strong Potential
- 3 REITs to Buy and Hold for the Long Term
- Trade War Bargain Stocks: Top 3 Picks Too Good to Pass Up
Receive News & Ratings for Precipio Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Precipio and related companies with MarketBeat.com's FREE daily email newsletter.